Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Winther-Larsen

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Clinical Lung Cancer|November 22, 2025
Advanced Lung Cancer Inflammation Index has Prognostic Impact in Stage I Non-Small Cell Lung Cancer: A Registry-Based Analysis of 934 PatientsCamilla Højbjerg Gregersen, Ninna Aggerholm-Pedersen, Birgitte Sandfeld-Paulsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 8, 2019
Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and childrenAgnes Ziobrowska-Bech, Anne Winther-Larsen, Britta Kremke, et al.
Lung Cancer (Amsterdam, Netherlands)|July 15, 2014
EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinibAnne Winther Larsen, Peter Henrik Nissen, Peter Meldgaard, et al.
Oncotarget|August 21, 2018
A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutationsChristina Demuth, Anne Winther-Larsen, Anne Tranberg Madsen, et al.
Cancers|April 16, 2020
Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer PatientsAnne Tranberg Madsen, Anne Winther-Larsen, Tine McCulloch, et al.
Clinical Biochemistry|October 31, 2025
A novel 17.9 kb deletion of the beta-globin gene causing beta-thalassemia trait in a Danish maleHelle Pilgaard Kristiansen, Jesper Petersen, Peter Schou, et al.
Clinical Chemistry and Laboratory Medicine|July 13, 2026
Flow cytometric analysis of peritoneal dialysis fluid in suspected peritonitis: diagnostic performance and limitationsLea Tybirk, Helle Pilgaard Kristiansen, Mie Samson, et al.
Acta Oncologica (Stockholm, Sweden)|July 24, 2015
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapyAnne Winther-Larsen, Lone Hoffmann, Ditte S Moeller, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Assessment of very early response evaluation with <sup>18</sup>F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methodsJoan Fledelius, Anne Winther-Larsen, Azza A Khalil, et al.
Clinical Chemistry and Laboratory Medicine|March 1, 2023
Short-term biological variation of plasma uracil in a Caucasian healthy populationAnne Winther-Larsen, Anne Tranberg Madsen, Peter H Nissen, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Clinical Lung Cancer|November 22, 2025
Advanced Lung Cancer Inflammation Index has Prognostic Impact in Stage I Non-Small Cell Lung Cancer: A Registry-Based Analysis of 934 PatientsCamilla Højbjerg Gregersen, Ninna Aggerholm-Pedersen, Birgitte Sandfeld-Paulsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 8, 2019
Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and childrenAgnes Ziobrowska-Bech, Anne Winther-Larsen, Britta Kremke, et al.
Lung Cancer (Amsterdam, Netherlands)|July 15, 2014
EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinibAnne Winther Larsen, Peter Henrik Nissen, Peter Meldgaard, et al.
Oncotarget|August 21, 2018
A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutationsChristina Demuth, Anne Winther-Larsen, Anne Tranberg Madsen, et al.
Cancers|April 16, 2020
Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer PatientsAnne Tranberg Madsen, Anne Winther-Larsen, Tine McCulloch, et al.
Clinical Biochemistry|October 31, 2025
A novel 17.9 kb deletion of the beta-globin gene causing beta-thalassemia trait in a Danish maleHelle Pilgaard Kristiansen, Jesper Petersen, Peter Schou, et al.
Clinical Chemistry and Laboratory Medicine|July 13, 2026
Flow cytometric analysis of peritoneal dialysis fluid in suspected peritonitis: diagnostic performance and limitationsLea Tybirk, Helle Pilgaard Kristiansen, Mie Samson, et al.
Acta Oncologica (Stockholm, Sweden)|July 24, 2015
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapyAnne Winther-Larsen, Lone Hoffmann, Ditte S Moeller, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Assessment of very early response evaluation with <sup>18</sup>F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methodsJoan Fledelius, Anne Winther-Larsen, Azza A Khalil, et al.
Clinical Chemistry and Laboratory Medicine|March 1, 2023
Short-term biological variation of plasma uracil in a Caucasian healthy populationAnne Winther-Larsen, Anne Tranberg Madsen, Peter H Nissen, et al.
Pageof 5